Valuation: AbbVie Inc.

Market Cap 447B 391B 360B 333B 633B 42,623B 643B 4,314B 1,691B 20,931B 1,676B 1,640B 72,501B P/E 2026 *
30.5x
P/E 2027 * 23.7x
Enterprise Value 502B 439B 405B 374B 711B 47,873B 722B 4,845B 1,899B 23,509B 1,883B 1,842B 81,432B EV / Sales 2026 *
7.46x
EV / Sales 2027 * 6.78x
Free-Float
95.71%
Yield 2026 *
2.72%
Yield 2027 * 2.86%
1 day-1.72%
1 week-4.61%
Current month-1.03%
1 month+10.48%
3 months+17.25%
6 months+13.16%
Current year+8.99%
1 week 248.96
Extreme 248.965
260.92
1 month 215.37
Extreme 215.37
261.64
Current year 190.75
Extreme 190.75
261.64
1 year 184.63
Extreme 184.63
261.64
3 years 132.7
Extreme 132.7
261.64
5 years 105.56
Extreme 105.56
261.64
10 years 55.06
Extreme 55.0623
261.64
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 68 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

62 0.0000%
06-29Free

Director

134 0.0000%
05-07Free

Director

1,118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%-4.61%+30.65%+85.17% 447B
-0.37%+0.14%+54.48%+168.26% 1,084B
-1.72%-1.32%+66.09%+62.73% 634B
+0.18%-1.76%+29.04%+26.48% 330B
-6.22%-8.14%+28.87%+31.18% 295B
-1.27%-2.91%+27.42%+44.91% 285B
-0.93%-3.57%-27.74%-39.70% 218B
-1.45%-2.89%+22.54%+61.68% 199B
-1.38%+2.09%+18.34%+77.05% 169B
+0.60%-0.31%-5.14%-32.05% 137B
Average -1.42%+2.34%+24.46%+48.57% 379.69B
Weighted average by Cap. -1.30%+2.42%+37.24%+79.84%

Financials

2026 *2027 *
Net sales 67.24B 58.82B 54.24B 50.19B 95.26B 6,418B 96.85B 650B 255B 3,152B 252B 247B 10,917B 72.74B 63.64B 58.68B 54.3B 103B 6,943B 105B 703B 275B 3,410B 273B 267B 11,811B
Net income 14.35B 12.56B 11.58B 10.71B 20.33B 1,370B 20.67B 139B 54.36B 673B 53.88B 52.72B 2,330B 19.02B 16.64B 15.35B 14.2B 26.95B 1,816B 27.4B 184B 72.04B 892B 71.42B 69.87B 3,089B
Net Debt 55B 48.12B 44.37B 41.06B 77.92B 5,250B 79.23B 531B 208B 2,578B 206B 202B 8,931B 46.43B 40.61B 37.45B 34.65B 65.77B 4,432B 66.87B 449B 176B 2,176B 174B 171B 7,538B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-07-09 US$249.03 -1.47% 2,386,868
26-07-08 US$252.74 -0.75% 7,578,707
26-07-07 US$254.65 -0.04% 8,238,267
26-07-06 US$254.76 -2.42% 8,580,220
26-07-02 US$261.07 +3.99% 7,114,422
Trader
Investor
Global
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
252.74USD
Average target price
259.46USD
Spread / Average Target
+2.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock